|
No. of Epidermal Tumours |
No. of Adnexal Tumours |
No.of Melanocytic
Tumours |
Benign |
6 (11.54%) |
8 (15.38%) |
9 (17.31%) |
Malignant |
21(40.38%) |
2 (3.85) |
6 (11.54%) |
Total no. of cases |
27 |
10 |
15 |
Number of Cases |
Percentages (%) |
|
Epidermal |
21 |
72.41 |
Squamous Cell Carcinoma |
14 |
48.27 |
Verrucous Squamous Cell
Carcinoma |
3 |
10.34 |
Basal Cell Carcinoma |
7 |
24.13 |
Malignant melanoma |
6 |
20.69 |
AcralLentiginous Melanoma |
1 |
3.45 |
Superficial Melanoma |
2 |
6.89 |
Nodular Melanoma |
2 |
6.89 |
Ulcerated Melanoma |
1 |
3.44 |
Adnexal |
2 |
6.90 |
Proliferating Tricholemmoma |
2 |
6.90 |
Total |
29 |
100 |
Skin Appendegeal Tumour |
No of Benign Tumour |
No. of Malignant Tumour |
Total no. of Tumour |
Tumour with Eccrine and Apocrine differentiation |
7 |
- |
7 |
Tumour with Hair follicle Differentiation |
1 |
2 |
3 |
Total |
8 |
2 |
10 |
Type of tumour |
Deo SV et al (2005)[12] |
Sonam SK et al (2011)[10] |
Present study |
Squamous cellCarcinoma |
55.8% |
64% |
48.27% |
Basal cellCarcinoma |
18.1% |
22.5% |
24.14% |
Malignant melanoma |
26.1% |
6.7% |
20.69% |
AdnexalCarcinoma |
- |
6.8% |
6.90% |
Studied Observations |
Benign |
Malignant |
Totalno of Cases |
||
No |
% |
No |
% |
|
|
Radhika K et al (2013)[14] |
27 |
77.14 |
8 |
22.85 |
35 |
Sonam SK et al (2011)[10] |
25 |
80.6 |
6 |
19.4 |
31 |
Ankit Sharma et al (2014)[15] |
45 |
80.36 |
11 |
19.64 |
56 |
Rajalakshmi T et al (2013)[5] |
53 |
77.94 |
15 |
22.05 |
68 |
Kaur A et al (2018)[16] |
91 |
82.73 |
19 |
17.27 |
110 |
Paudyal P et al (2016)[17] |
68 |
97.1 |
2 |
2.9 |
70 |
Deka M et al(2016)[18] |
17 |
73.92 |
6 |
26.08 |
23 |
Present study |
8 |
80 |
2 |
20 |
10 |